Clinical Trials Logo

Bone Neoplasms clinical trials

View clinical trials related to Bone Neoplasms.

Filter by:

NCT ID: NCT03204942 Completed - Clinical trials for Bone Neoplasm,Malignant Vertebral Column Thoracic Secondary

Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral Body

Start date: February 14, 2017
Phase: N/A
Study type: Interventional

AIM OF THE WORK To evaluate the effectiveness and safety of Pulsed and Thermal Radiofrequency lesion of the dorsal root ganglion (RF-DRG) on a consecutive group of patients presenting with chronic thoracic pain due to vertebral bone metastasis.

NCT ID: NCT03188926 Completed - Surgery Clinical Trials

Surgical Treatment of Long Bone Metastases

MTC
Start date: January 4, 2016
Phase:
Study type: Observational [Patient Registry]

To provide treatment guidelines for patients with long bone metastatic disease based on observational study and to propose an algorithm to guide orthopedic surgeons in decision-making for these patient.

NCT ID: NCT03072186 Completed - Neoplasms Clinical Trials

Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base Surgery

ICG2
Start date: November 6, 2017
Phase: N/A
Study type: Interventional

This study is being done to demonstrate the feasibility of using a nasal endoscope to perform intraoperative angiography of surgical field, with the goals to evaluate anatomical landmarks and tumor characteristics during skull base surgery and publish a technical note.

NCT ID: NCT02996734 Completed - Clinical trials for Giant Cell Tumor of Bone

Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment

GCTLIMBS
Start date: April 2016
Phase: N/A
Study type: Observational

The purpose of this project is to present the outcomes of patients with giant cell tumor of bone (GCTB) who were treated with surgery and/or medical treatment in a single institution.

NCT ID: NCT02969564 Completed - Prostate Cancer Clinical Trials

18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.

Start date: May 2016
Phase:
Study type: Observational

The number of metastases in a patient with primary or recurrent prostate cancer has major prognostic implication. The purpose is to compare, in a pilot study, the diagnostic performance of 18F-NaF-PET/MR with respect to the results of the scintigraphy 99mTc-MDP-SPECT/CT (routine exam) for determining the presence or absence of bone lesions in prostate cancer patient, with up to five metastases (oligo-bone metastatic) based on scintigraphy 99mTc-MDP-SPECT/CT. The gold standard will be a combination of clinical follow-up, additional imaging and biopsy, as indicated by the multidisciplinary discussion at the tumor board. The findings from whole-body 99mTc-MDP-SPECT/CT, 18F-NaF-PET/MR, and the combination of the 2 modalities will be categorized by 2 teams of 2 readers as benign or probably benign, equivocal, or malignant or probably malignant and compared with the results of follow-up for JAFROC and ROC analysis.

NCT ID: NCT02901782 Completed - Bone Tumors Clinical Trials

The Application of Personalized Titanium Plate in the Bone Tumors Around the Knee

Start date: January 2013
Phase: N/A
Study type: Interventional

Microwave ablation of bone tumors is time-consuming and usually results in postoperative fractures. Hence the investigators designed and fabricated a titanium plate customized to the patient's bone structures for fixation after the removal of tumorous tissue, to improve the clinical outcomes of microwave ablation.

NCT ID: NCT02887833 Completed - Pain Clinical Trials

Thermal Testing in Bone Pain (TiBoP)

TiBoP
Start date: October 2016
Phase:
Study type: Observational

If cancer spreads to bones it can be very painful, especially when trying to move around. One of the best treatments is radiotherapy, which has to be given in a cancer centre. Even with this treatment, only about half of people will get good pain relief, and that can take up to 6 weeks to work fully. If we know who is unlikely to benefit , then we can explore other forms of pain relief sooner, without having to go through radiotherapy unnecessarily. We have found that there may be a very simple way to identify patients likely to get good pain relief, using a test of changes in temperature sensation over the painful bone. This study will explore whether this simple bedside test can be used in a community setting to identify which patients suffering from cancer induced bone pain will get good pain relief from radiotherapy.

NCT ID: NCT02876731 Completed - Cancer Clinical Trials

Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)

IMMETAOS
Start date: July 2013
Phase: N/A
Study type: Interventional

Prospective, monocentric, comparative, non randomised Primary objective : - to compare the diagnostic accuracy of sodium fluoride PET-CT and MRI using the conventional block and diffusion sequence in the search for bone metastases Secondary objectives : - compare accuracy of MRI diffusion and conventional MRI - explore the evolution of the results of the different types of imaging over time or under treatment for patients with repeated examinations at 6 months

NCT ID: NCT02862288 Completed - Bone Tumor Clinical Trials

Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.

TherMO
Start date: September 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The aims of this work were to assess the feasibility, efficacy, short-term outcome and safety of microwave ablation in the treatment of malignant bone, lung and renal tumors.

NCT ID: NCT02826382 Completed - Prostate Cancer Clinical Trials

Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041

Start date: September 20, 2016
Phase: Early Phase 1
Study type: Interventional

A phase1 study to demonstrate [68Ga]P15-041 binding to bone metastases in prostate cancer and determination of human dosimetry.